- IP Mentor for One Nucleus
Partner at Mathys & Squire LLP
Craig Titmus is a partner in the life sciences team at Mathys & Squire. Dr Titmus has an extensive European and international patent prosecution practice and coordinates global IP portfolios for a range of clients including start-ups, small and medium-sized enterprises (SMEs), universities, large corporations and the UK government.
Dr Titmus has considerable experience within the life sciences sector and is recognised for his ability to work with technologically diverse subject matter. He has a strong track record in identifying and obtaining valuable patent protection for vaccines, diagnostics, therapeutic antibodies, viral vector-based therapies and biofuels, as well as for clients working on interdisciplinary technologies. Dr Titmus is renowned for his pragmatic advice and takes great pleasure in collaborating with clients to identify creative and commercially relevant IP filing strategies. Throughout his career, Dr Titmus has been responsible for establishing and developing IP portfolios that underpin a number of successful UK start-ups and SMEs.
Before entering the profession, Dr Titmus gained a first-class bachelor’s degree in molecular biology and biochemistry at the University of Durham where he ranked top in his year. He then went on to the University of Cambridge to undertake a PhD in collaboration with a multinational crop research company, during which time he was awarded various PhD prizes within the Institute of Biotechnology.
Dr Titmus was also recommended in the 2019 and 2020 editions of the IAM Patent 1000 guide, where he was described by clients as a “lifesaver” and a “true strategic partner”. He also features regularly in The Legal 500, with the latest edition highlighting Dr Titmus as “an exceptional lawyer” who “presents the commentary and issues with such clarity”.